Scott J Russo

Icahn School of Medicine at Mount Sinai · company speakers →

In this session, the speaker will present cross-species data to understand how peripheral immune cells interact with the brain to regulate circuits involved in depression and anxiety. It also highlights translational efforts to study stress-induced neuroimmune dysfunction, including inflammation and monocytosis. These findings underscore the need for targeted therapies to treat major depressive disorder (MDD) and post-traumatic stress disorder (PTSD) by modulating neuroimmune pathways.

healthcare-servicespharma-biotech

Is this you? Claim this profile →

No public contact links on file.

Speaking history

Neuroscience

14 November 2026 Washington, United States “Building a Translational Research Program to Study the Neuroimmune Mechanisms of Depression”

Neuroscience

13 November 2027 Chicago, United States “Building a Translational Research Program to Study the Neuroimmune Mechanisms of Depression”

Neuroscience

11 November 2028 San Diego, United States “Building a Translational Research Program to Study the Neuroimmune Mechanisms of Depression”

Topics this speaker covers

healthcare-servicespharma-biotech

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →